Where does Veran Medical Technologies, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Veran Medical Technologies, Inc. ranks #8,144 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Veran Medical Technologies, Inc. hold?

Veran Medical Technologies, Inc. holds 40 US utility patents granted between 2015 and 2025, spanning 7 technology areas.

What is Veran Medical Technologies, Inc.'s Innovation Score?

Veran Medical Technologies, Inc. has an Innovation Score of 37.9 out of 100 (top 42% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Veran Medical Technologies, Inc. focus on?

Veran Medical Technologies, Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 35 patents, ranking #539 of 7,127 assignees active in that subclass. Grants appear in 7 CPC subclasses total.

Is Veran Medical Technologies, Inc.'s patent grant rate increasing or decreasing?

Veran Medical Technologies, Inc.'s recent grant velocity is +189% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Veran Medical Technologies, Inc.'s patents?

Veran Medical Technologies, Inc.'s patents average 15.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Veran Medical Technologies, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Veran Medical Technologies, Inc.

USPTO PatentsView assignee record - 40 granted patents across 7 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Veran ranks #8,144 of 49,997 tracked US assignees by granted-patent volume, with 40 patents across 7 technology areas.

#8,144
of 49,997 US assignees by volume: Top 42%
by Innovation Score (37.9/100): 15.1
avg claims per patent: +189%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R8144 · US Corporation #8,144 · 40 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 40 grants
UPPER-Q #8,144/49,997
PHOTO-FINISH Vasona Networks
CPC-NARROW A61B · 7 areas
INNOV-THIN 37.9/100
CLAIMS-RICH 15.1 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +189% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Vasona Networks, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Veran’s 37.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 12.8 pts (34%) Velocity 6.7 pts (18%) Breadth 9.4 pts (25%) Claim depth 9.1 pts (24%)

Qualcomm Incorporated · highest

85
Banner Life Sciences · near

38
Barrette Outdoor… · near

38
First American… · near

38
LM Glasfiber A/S · near

38
Veran Medical · this assignee

38
3D Lighting… · lowest

7

What this shows Veran's Innovation Score is 37.9/100 (top 42% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Veran?

Each dot is one of Veran’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Veran’s own 15.1 claims/patent is ABOVE the 9.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Veran vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Veran's grants concentrate

Veran Medical Technologies, Inc. is a focused PatentsView assignee: 7 CPC subclasses with 87.5% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2023 (8 grants) versus a trough of 2 in 2018. By volume, Veran sits between Velo3d, Inc. and Zojirushi Corporation.

Veran's three-year grant acceleration

Veran Medical Technologies, Inc. shows 15 grants in 2022–2024 against only 15 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Velo3d

40
Vasona Networks

40
Vector Products

40
Velocys

40
Volta Charging

40
Walter R Tucker E…

40
X-card Holdings

40
Zojirushi

40
Veran Medical ◀

40

What this shows Veran holds 40 patents at rank #8,142, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Veran

By rank, the assignees closest to #8,142 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Veran's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Veran, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), Veran ranks #539 of 7,127 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (38 here).

Banner Life Sciences LLC 38 Barrette Outdoor Living, Inc. 38 LM Glasfiber A/S 38 First American Financial Corporation 38

Veran's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

38 Top 42% higher than 58% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Veran Medical Technologies, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	3	7.5%
2018	2	5.0%
2019	4	10.0%
2020	6	15.0%
2021	5	12.5%
2022	5	12.5%
2023	8	20.0%
2024	2	5.0%
2025partial year	5	12.5%

Which technologies does Veran Medical Technologies, Inc. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 35

G06T - Image Data Processing OR Generation, IN General 24

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 16

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 8

G01S - Radio DIRECTION-FINDING; Radio NAVIGATION; Determining Distance OR Velocity BY USE OF Radio WAVES; Locating OR Presence-detecting BY USE OF THE Reflection OR Reradiation OF Radio WAVES; Analogous Arrangements Using Other Waves 2

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 1

G06N - Computing Arrangements Based ON Specific Computational Models 1

Top 7 of 7 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Veran Medical Technologies, Inc.'s patent record in context - here's where to go next.

Veran Medical Technologies, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 87.5% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #8,144 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Veran Medical Technologies, Inc. against Velo3d, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 37.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.